Diminished alpha2-plasmin inhibitor activity associated with the use of imatinib mesylate in patients with Philadelphia chromosome-positive haematologic cancer
Keitaro Matsuo(Aichi Cancer Center), Kosei Matsue(Kameda Medical Center), Kanichi Iwama(Kameda Medical Center), Hideaki Fujiwara(University of Michigan), Shun‐ichi Kimura(Nihon University), Masayuki Yamakura(Kameda Medical Center), Masami Takeuch(Kameda Medical Center), Brian Hayama(Japanese Foundation For Cancer Research)
Cited by 0
Related Papers
Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation
|Blood|2017|352
Differences in incidence and trends of haematological malignancies in <scp>J</scp>apan and the <scp>U</scp>nited <scp>S</scp>tates
|British Journal of Haematology|2013|306
Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study
|Blood|2010|288
Adult height and head and neck cancer: A pooled analysis within the INHANCE Consortium
|Consultation of the Doctoral Thesis Database (TESEO) (Ministerio de Educación, Cultura y Deporte)|2014|265
Diet and the risk of head and neck cancer: a pooled analysis in the INHANCE consortium
|Cancer Causes & Control|2011|164